PlainRecalls
FDA Drug Moderate Class II Terminated

Fosphenytoin Sodium Injection, USP, 100 mg PE per 2 mL (50 mg PE per mL), 2 mL Single Dose Vial, packaged in 25-count x 2 mL Single Dose Vials per carton, Rx only, Mfd. By: Hikma Farmaceutica (Portugal), S.A.; Dist. By: West-Ward Pharmaceutical Corp., Eatontown, NJ 07724 USA under the labels a) NOVAPLUS (NDC 0143-9704-25), b) West-Ward (NDC 0143-9788-25).

Reported: August 8, 2012 Initiated: April 13, 2012 #D-1437-2012

Product Description

Fosphenytoin Sodium Injection, USP, 100 mg PE per 2 mL (50 mg PE per mL), 2 mL Single Dose Vial, packaged in 25-count x 2 mL Single Dose Vials per carton, Rx only, Mfd. By: Hikma Farmaceutica (Portugal), S.A.; Dist. By: West-Ward Pharmaceutical Corp., Eatontown, NJ 07724 USA under the labels a) NOVAPLUS (NDC 0143-9704-25), b) West-Ward (NDC 0143-9788-25).

Reason for Recall

Presence of Particulate Matter: This product is being recalled due to the discovery of particles in the stability samples and retain samples.

Details

Units Affected
a) 308,275 vials; b) 2,008,850 vials
Distribution
All lots were distributed throughout the US.
Location
Eatontown, NJ

Frequently Asked Questions

What product was recalled?
Fosphenytoin Sodium Injection, USP, 100 mg PE per 2 mL (50 mg PE per mL), 2 mL Single Dose Vial, packaged in 25-count x 2 mL Single Dose Vials per carton, Rx only, Mfd. By: Hikma Farmaceutica (Portugal), S.A.; Dist. By: West-Ward Pharmaceutical Corp., Eatontown, NJ 07724 USA under the labels a) NOVAPLUS (NDC 0143-9704-25), b) West-Ward (NDC 0143-9788-25).. Recalled by West-ward Pharmaceutical Corp.. Units affected: a) 308,275 vials; b) 2,008,850 vials.
Why was this product recalled?
Presence of Particulate Matter: This product is being recalled due to the discovery of particles in the stability samples and retain samples.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 8, 2012. Severity: Moderate. Recall number: D-1437-2012.